This is a 12-week open label trial to evaluate whether omega-3 fatty acids is effective in reducing the severity of autism and its comorbidities.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Institute of Mental Health
Singapore, Singapore
Change from baseline in parent rated Social Responsiveness Scale (SRS) scores during treatment
Time frame: 12 weeks
Change from baseline in parent rated Child Behavior Checklist (CBCL) scores during treatment
Time frame: 12 weeks
Change from baseline in teacher rated Teacher Report (TRF) scores during treatment
Time frame: 12 weeks
Change from baseline in teacher rated Social Responsiveness Scale (SRS) scores during treatment
Time frame: 12 weeks
Change from baseline in clinician rated Clinical Global Impression (Severity and Improvements) scores during treatment
Time frame: 12 weeks
Change from baseline in clinician rated Global Assessment of Functioning (GAF) scores during treatment
Time frame: 12 weeks
Children's Yale-Brown Obsessive Compulsive Scale modified for Pervasive Developmental Disorders (CYBOCS-PDD)
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.